Næste

Automatisk afspilning

Olaratumab Plus Doxorubicin in Advanced Soft Tissue Sarcoma

2 Visninger • 07/18/23
Del
Indlejre
administrator
administrator
Abonnenter
0

William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses results from a phase Ib/II presented at the 2015 Connective Tissue Oncology Society (CTOS) Annual Meeting.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning